In the present study, we examined whether serum EV miRNA profiles could be used to distinguish rheumatoid arthritis from ankylosing spondylitis, as well as to predict outcome of TNF inhibitor treatment in both of these rheumatic diseases. The gene discussed is TNF; the disease is ankylosing spondylitis.